Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Covington
Merck
Teva
Colorcon
UBS
Farmers Insurance
Fuji
Fish and Richardson
QuintilesIMS

Generated: January 22, 2018

DrugPatentWatch Database Preview

Erythromycin - Generic Drug Details

« Back to Dashboard

What are the generic sources for erythromycin and what is the scope of erythromycin patent protection?

Erythromycin
is the generic ingredient in fifty-two branded drugs marketed by Mayne Pharma, Parke Davis, Warner Chilcott Llc, Hospira, Arbor Pharms Llc, Barr, Mylan Pharms Inc, Altana, Fougera Pharms, Perrigo Co, Teligent Pharma Inc, Syosset, Akorn, Bausch And Lomb, Perrigo Co Tennessee, Pharmaderm, Pharmafair, Dista, Dow Pharm, Paddock Llc, Taro, Arbor Pharms Inc, Merz Pharms, Saptalis Pharms, Hi Tech Pharma, Alpharma Us Pharms, Lilly, Perrigo New York, Renaissance Pharma, Wockhardt, Westwood Squibb, Ivax Sub Teva Pharms, Johnson And Johnson, Solvay, Robins Ah, Watson Labs, G And W Labs Inc, Life Labs, Ani Pharms Inc, Ross Labs, Pharmacia And Upjohn, Naska, Wyeth Ayerst, Mylan, Alra, Abbott, Elkins Sinn, Abraxis Pharm, Baxter Hlthcare, Teva Parenteral, Bristol, Warner Chilcott, Lederle, Purepac Pharm, Bristol Myers Squibb, and Pfizer, and is included in one hundred and twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and one drug master file entries for erythromycin. Thirty-eight suppliers are listed for this compound.
Pharmacology for erythromycin
Medical Subject Heading (MeSH) Categories for erythromycin

US Patents and Regulatory Information for erythromycin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dista ILOTYCIN GLUCEPTATE erythromycin gluceptate INJECTABLE;INJECTION 050370-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Parenteral ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 063253-002 Jul 30, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Arbor Pharms Llc ERY-TAB erythromycin TABLET, DELAYED RELEASE;ORAL 062298-001 Approved Prior to Jan 1, 1982 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062353-001 Nov 18, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062993-001 May 9, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Arbor Pharms Llc ERYTHROCIN STEARATE erythromycin stearate TABLET;ORAL 060359-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr E-BASE erythromycin TABLET, DELAYED RELEASE;ORAL 063028-001 May 15, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate SUSPENSION;ORAL 062231-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062993-002 May 9, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fougera Pharms C-SOLVE-2 erythromycin SOLUTION;TOPICAL 062468-001 Jul 3, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Cantor Fitzgerald
QuintilesIMS
Medtronic
Dow
Federal Trade Commission
AstraZeneca
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot